All STXBP1 encephalopathy patients have intellectual disability, and 80–90% of the patients have epilepsy and motor dysfunctions (Stamberger et al., 2016; Abramov et al., 2021; Xian et al., 2022). The gene discussed is STXBP1; the disease is epilepsy.